Cargando…
A Case Series of Severe Hyperammonemia Encephalopathy Related to Valproate: Can Antipsychotics Increase the Risk?
Valproate-induced hyperammonemia is a common side effect of valproate, which may occur either without any symptoms or may rarely cause symptoms of encephalopathy. Different risk factors have been defined for this side effect, including some nutritional deficiencies and polypharmacy (eg, other antico...
Autores principales: | Davoudi-Monfared, Effat, Radmehr, Mojan, Ghaeli, Padideh, Mousavi, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Psychiatry & Psychology Research Center, Tehran University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778604/ https://www.ncbi.nlm.nih.gov/pubmed/31598129 |
Ejemplares similares
-
The Menacing Side of Valproate: A Case Series of Valproate-induced Hyperammonemia
por: Elwadhi, Deeksha, et al.
Publicado: (2017) -
Levocarnitine for valproate-induced hyperammonemia in the psychiatric setting: A case series and literature review
por: Brown, Lauren M., et al.
Publicado: (2018) -
Hyperammonemia Is Associated with Increasing Severity of Both Liver Cirrhosis and Hepatic Encephalopathy
por: Khan, Abidullah, et al.
Publicado: (2016) -
Methylphenidate-Induced Psychotic Symptoms in 65-Year-Old Female with ADHD
por: Ghadrdan, Elliyeh, et al.
Publicado: (2018) -
Use of carglumic acid in valproate‐induced hyperammonemia: 25 pediatric cases
por: Palomino Pérez, Laura María, et al.
Publicado: (2020)